CLINICAL_TRIALS
trial_result
· 2025-12-30
Clinical Trial Update: Microdosing Psychedelics to Improve Mood [Phase 2]
Summary
A Phase 2 clinical trial investigating microdosing psychedelics to improve mood in adults with Major Depressive Disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rotem Petranker | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED